Laboratory Co. of America Holdings (NYSE: LH) had its price target raised by analysts at Morgan Stanley from $260.00 to $270.00. They now have an "overweight" rating on the stock.
LowReport
Laboratory Co. of America Holdings (NYSE: LH) had its price target raised by analysts at Morgan Stanley from $260.00 to $270.00. They now have an "overweight" rating on the stock.
Rare Disease Diagnostics Emerging Technologies and Developments Report - Shift Towards a Multi-omics Approach, Collaboration Between Rare Disease Diagnostics and Pharma Companies [Yahoo! Finance]
LowReport
Rare Disease Diagnostics Emerging Technologies and Developments Report - Shift Towards a Multi-omics Approach, Collaboration Between Rare Disease Diagnostics and Pharma Companies [Yahoo! Finance]
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: